Daoling Bi

1.5k total citations
15 papers, 800 citations indexed

About

Daoling Bi is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Daoling Bi has authored 15 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Health and 6 papers in Infectious Diseases. Recurrent topics in Daoling Bi's work include Virology and Viral Diseases (12 papers), Vaccine Coverage and Hesitancy (10 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Daoling Bi is often cited by papers focused on Virology and Viral Diseases (12 papers), Vaccine Coverage and Hesitancy (10 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Daoling Bi collaborates with scholars based in United States, Argentina and United Kingdom. Daoling Bi's co-authors include Charles W. LeBaron, Carol L. Beck, Bradley J. Sullivan, Bagher Forghani, David Sugerman, Paul A. Rota, Kimberly Ralston, Maryann G. Delea, Ismael R. Ortega‐Sanchez and Albert E. Barskey and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Daoling Bi

15 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daoling Bi United States 13 647 467 285 98 96 15 800
Jennifer B. Rosen United States 18 839 1.3× 386 0.8× 247 0.9× 195 2.0× 86 0.9× 41 1.1k
Gina Tambini United States 16 435 0.7× 317 0.7× 229 0.8× 36 0.4× 83 0.9× 22 675
Albert E. Barskey United States 18 1.0k 1.6× 583 1.2× 385 1.4× 63 0.6× 158 1.6× 30 1.4k
Jolita Mereckiene Ireland 15 955 1.5× 566 1.2× 237 0.8× 88 0.9× 36 0.4× 27 1.2k
Martti Valle Finland 11 516 0.8× 339 0.7× 229 0.8× 36 0.4× 114 1.2× 13 764
J. Batalla Spain 15 484 0.7× 226 0.5× 205 0.7× 120 1.2× 40 0.4× 47 646
L. E. Markowitz United States 13 374 0.6× 227 0.5× 167 0.6× 50 0.5× 141 1.5× 16 532
Sari Jokinen Finland 9 532 0.8× 274 0.6× 284 1.0× 26 0.3× 94 1.0× 13 653
FT Cutts United Kingdom 8 583 0.9× 200 0.4× 125 0.4× 39 0.4× 95 1.0× 11 748
S E Robertson United States 8 323 0.5× 161 0.3× 221 0.8× 59 0.6× 35 0.4× 10 545

Countries citing papers authored by Daoling Bi

Since Specialization
Citations

This map shows the geographic impact of Daoling Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoling Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoling Bi more than expected).

Fields of papers citing papers by Daoling Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoling Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoling Bi. The network helps show where Daoling Bi may publish in the future.

Co-authorship network of co-authors of Daoling Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Daoling Bi. A scholar is included among the top collaborators of Daoling Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoling Bi. Daoling Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Burke, Rachel M., Claire P. Mattison, Talia Pindyck, et al.. (2020). Burden of Norovirus in the United States, as Estimated Based on Administrative Data: Updates for Medically Attended Illness and Mortality, 2001–2015. Clinical Infectious Diseases. 73(1). e1–e8. 47 indexed citations
2.
Marin, Mona, Amy Parker Fiebelkorn, Daoling Bi, et al.. (2020). Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine. Clinical Infectious Diseases. 73(7). e1546–e1553. 13 indexed citations
3.
Rha, Brian, Rebecca M. Dahl, Jocelyn Moyes, et al.. (2018). Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness—South Africa, 2009–2014. Journal of the Pediatric Infectious Diseases Society. 8(4). 325–333. 25 indexed citations
4.
Fiebelkorn, Amy Parker, Laura A. Coleman, Edward A. Belongia, et al.. (2015). Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults. The Journal of Infectious Diseases. 213(7). 1115–1123. 39 indexed citations
5.
Fiebelkorn, Amy Parker, Laura A. Coleman, Edward A. Belongia, et al.. (2014). Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine. Open Forum Infectious Diseases. 1(3). ofu094–ofu094. 54 indexed citations
6.
Fiebelkorn, Amy Parker, Laura A. Coleman, Edward A. Belongia, et al.. (2014). 1339Measles and Mumps Antibody Response in Young Adults after a Third Dose of Measles-Mumps-Rubella Vaccine. Open Forum Infectious Diseases. 1(suppl_1). S58–S58. 3 indexed citations
7.
Sugerman, David, Albert E. Barskey, Maryann G. Delea, et al.. (2010). Measles Outbreak in a Highly Vaccinated Population, San Diego, 2008: Role of the Intentionally Undervaccinated. PEDIATRICS. 125(4). 747–755. 227 indexed citations
8.
LeBaron, Charles W., Bagher Forghani, L Matter, et al.. (2009). Persistence of Rubella Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine. The Journal of Infectious Diseases. 200(6). 888–899. 57 indexed citations
9.
LeBaron, Charles W., Bagher Forghani, Carol L. Beck, et al.. (2008). Persistence of Mumps Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine. The Journal of Infectious Diseases. 199(4). 552–560. 69 indexed citations
10.
Dayan, Gustavo H., et al.. (2007). Medical practices for prevention of perinatal infections in Puerto Rico. Paediatric and Perinatal Epidemiology. 22(1). 31–39. 4 indexed citations
11.
LeBaron, Charles W., Judith Beeler, Bradley J. Sullivan, et al.. (2007). Persistence of Measles Antibodies After 2 Doses of Measles Vaccine in a Postelimination Environment. Archives of Pediatrics and Adolescent Medicine. 161(3). 294–294. 92 indexed citations
12.
LeBaron, Charles W., Daoling Bi, Bradley J. Sullivan, Carol L. Beck, & Paul Gargiullo. (2006). Evaluation of Potentially Common Adverse Events Associated With the First and Second Doses of Measles-Mumps-Rubella Vaccine. PEDIATRICS. 118(4). 1422–1430. 26 indexed citations
13.
Hyde, Terri B., Gustavo H. Dayan, Robin Nandy, et al.. (2005). Measles outbreak in the Republic of the Marshall Islands, 2003. International Journal of Epidemiology. 35(2). 299–306. 29 indexed citations
14.
Dayan, Gustavo H., Daria Ruth Galimberti, G. Carroli, et al.. (2005). Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002. Epidemiology and Infection. 133(5). 861–869. 19 indexed citations
15.
Bisgard, Kristine M., Philip Rhodes, Beverly L. Connelly, et al.. (2005). Pertussis Vaccine Effectiveness Among Children 6 to 59 Months of Age in the United States, 1998–2001. PEDIATRICS. 116(2). e285–e294. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer B. Rosen Breakdown of academic impact, for papers by Gina Tambini Breakdown of academic impact, for papers by Albert E. Barskey Breakdown of academic impact, for papers by Jolita Mereckiene Breakdown of academic impact, for papers by Martti Valle Breakdown of academic impact, for papers by J. Batalla Breakdown of academic impact, for papers by L. E. Markowitz Breakdown of academic impact, for papers by Sari Jokinen Breakdown of academic impact, for papers by FT Cutts Breakdown of academic impact, for papers by S E Robertson
Rankless by CCL
2026